Cost analysis for CPT J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
Average Medicare Payment
N/A
Total Payments (Latest)
N/A
Services (Latest)
N/A
Price Change (–)
N/A
The most expensive state pays 1.0x more than the cheapest for this procedure. RI averages $33.71 vs NM at $32.87.
| State | Avg Payment | Total Payments | Services | Providers |
|---|---|---|---|---|
| RI | $33.71 | $352.2K | 10.4K | 1 |
| ME | $33.68 | $828.6K | 24.6K | 4 |
| NH | $33.68 | $529.6K | 15.7K | 2 |
| CT | $33.67 | $1.1M | 33.4K | 4 |
| DC | $33.66 | $350.0K | 10.4K | 2 |
| PR | $33.65 | $364.3K | 10.8K | 2 |
| UT | $33.65 | $2.0M | 59.7K | 7 |
| KS | $33.65 | $5.2M | 155.9K | 18 |
| IA | $33.62 | $3.7M | 110.4K | 17 |
| MN | $33.58 | $5.6M | 166.3K | 23 |
| MS | $33.58 | $3.7M | 109.3K | 10 |
| MA | $33.58 | $3.8M | 114.5K | 15 |
| AZ | $33.57 | $15.8M | 471.3K | 32 |
| IL | $33.57 | $10.9M | 325.3K | 47 |
| TN | $33.56 | $10.9M | 324.3K | 30 |
| GA | $33.55 | $10.5M | 312.8K | 26 |
| WA | $33.54 | $4.8M | 143.1K | 23 |
| PA | $33.54 | $20.9M | 622.3K | 59 |
| MT | $33.52 | $1.3M | 37.7K | 5 |
| WI | $33.52 | $4.0M | 119.6K | 14 |
| ID | $33.51 | $3.0M | 88.3K | 8 |
| VA | $33.51 | $12.6M | 376.8K | 31 |
| AR | $33.50 | $8.5M | 254.3K | 16 |
| NC | $33.49 | $26.7M | 798.3K | 68 |
| NY | $33.49 | $11.0M | 329.2K | 41 |
| NE | $33.43 | $2.4M | 71.2K | 5 |
| NJ | $33.42 | $12.2M | 364.4K | 41 |
| OH | $33.42 | $10.4M | 312.4K | 36 |
| MD | $33.39 | $12.8M | 382.4K | 44 |
| AL | $33.39 | $10.6M | 316.1K | 27 |
| FL | $33.39 | $50.3M | 1.5M | 130 |
| NV | $33.35 | $1.5M | 44.6K | 5 |
| CO | $33.34 | $7.8M | 232.8K | 31 |
| MO | $33.34 | $10.2M | 306.0K | 23 |
| SD | $33.33 | $240.8K | 7.2K | 2 |
| MI | $33.33 | $5.4M | 162.8K | 19 |
| KY | $33.31 | $12.9M | 386.6K | 31 |
| TX | $33.31 | $40.5M | 1.2M | 103 |
| IN | $33.26 | $10.6M | 317.4K | 27 |
| DE | $33.26 | $3.9M | 117.0K | 9 |
| SC | $33.25 | $18.7M | 561.3K | 44 |
| WV | $33.24 | $598.5K | 18.0K | 2 |
| OK | $33.23 | $9.3M | 278.9K | 14 |
| LA | $33.21 | $6.6M | 198.1K | 13 |
| HI | $33.18 | $1.2M | 37.1K | 1 |
| OR | $33.07 | $5.5M | 165.6K | 21 |
| CA | $32.89 | $24.1M | 733.2K | 79 |
| NM | $32.87 | $3.2M | 98.2K | 9 |
| Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| Richard Houk | Rheumatology | AR | $2.6M | 77.8K | $33.55 |
| Nehal Gandhi | Rheumatology | PA | $2.4M | 72.6K | $33.72 |
| Aymen Kenawy | Rheumatology | FL | $2.2M | 66.9K | $33.15 |
| Grace Makhlouf | Rheumatology | TX | $2.0M | 60.3K | $33.63 |
| Abdelnaser Elkhalili | Rheumatology | TX | $1.9M | 55.1K | $33.74 |
| Craig Carson | Rheumatology | OK | $1.8M | 54.8K | $33.39 |
| Greg Eudy | Rheumatology | AL | $1.8M | 53.6K | $33.58 |
| Meera Oza | Rheumatology | FL | $1.6M | 48.6K | $33.74 |
| Joy Schechtman | Rheumatology | AZ | $1.4M | 42.7K | $33.64 |
| Rochelle Robicheaux Metoyer | Rheumatology | LA | $1.4M | 43.6K | $32.32 |
| Chaim Mond | Rheumatology | MD | $1.4M | 41.8K | $33.66 |
| Sona Kamat | Internal Medicine | MO | $1.4M | 41.7K | $33.58 |
| Vipul Joshi | Rheumatology | FL | $1.4M | 40.5K | $33.48 |
| Leslie Tar | Rheumatology | FL | $1.3M | 40.0K | $33.71 |
| Amir Agha | Rheumatology | FL | $1.3M | 39.7K | $33.70 |
| Anupam Chahal | Rheumatology | CA | $1.3M | 40.2K | $33.26 |
| Kevin Kempf | Rheumatology | TX | $1.3M | 39.6K | $33.46 |
| Mark Harris | Rheumatology | NC | $1.3M | 39.4K | $33.49 |
| David Lazar | Rheumatology | SC | $1.3M | 39.6K | $33.12 |
| Latisha Heinlen | Rheumatology | OK | $1.3M | 38.6K | $33.20 |
Based on the data, CPT J0129 shows a 1.0x variation in pricing across states — relatively consistent by Medicare standards.
Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.
This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.